Levy Adam Scott, CFO and Secretary of Mineralys Therapeutics, Inc. ($MLYS), made eighteen open market sales of company stock over the last 365 days, totaling about $7.5 million. His most recent sale occurred on January 12, 2026. These $MLYS insider sales rank 1,416th in value among 11,678 individual insiders, below the average of $8.6 million per seller but well above the average of 6.4 transactions. Levy Adam Scott recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | A | Stock Option | 53300 | $0.00 | 53,300.0000 | 79,139,956 | 9999.99% | 0.07% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | A | Common Stock | 39900 | $0.00 | 48,538.0000 | 79,139,956 | 461.91% | 0.05% |
| Jan. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 10758 | $32.14 | 8,638.0000 | 79,139,956 | 55.47% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 1015 | $42.00 | 137,905.0000 | 79,139,956 | 0.73% | 0.00% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | M | Common Stock | 20547 | $10.20 | 53,814.0000 | 79,139,956 | 61.76% | 0.03% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | M | Common Stock | 34414 | $16.00 | 88,228.0000 | 79,139,956 | 63.95% | 0.04% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | M | Common Stock | 44079 | $14.25 | 132,307.0000 | 79,139,956 | 49.96% | 0.06% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | M | Common Stock | 6613 | $15.44 | 138,920.0000 | 79,139,956 | 5.00% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 11295 | $41.87 | 126,610.0000 | 79,139,956 | 8.19% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 1561 | $42.68 | 125,049.0000 | 79,139,956 | 1.23% | 0.00% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 12952 | $41.65 | 112,097.0000 | 79,139,956 | 10.36% | 0.02% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 8485 | $42.34 | 103,612.0000 | 79,139,956 | 7.57% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 4142 | $43.50 | 99,470.0000 | 79,139,956 | 4.00% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 8456 | $45.18 | 91,014.0000 | 79,139,956 | 8.50% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 38900 | $45.93 | 52,114.0000 | 79,139,956 | 42.74% | 0.05% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 32718 | $46.88 | 19,396.0000 | 79,139,956 | 62.78% | 0.04% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | M | Stock Option | 20547 | $0.00 | 135,674.0000 | 79,139,956 | 13.15% | 0.03% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | M | Stock Option | 34414 | $0.00 | 20,662.0000 | 79,139,956 | 62.48% | 0.04% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | M | Stock Option | 44079 | $0.00 | 91,592.0000 | 79,139,956 | 32.49% | 0.06% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | M | Stock Option | 6613 | $0.00 | 4,888.0000 | 79,139,956 | 57.50% | 0.01% |
| Oct. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 3392 | $42.26 | 116,865.0000 | 49,835,637 | 2.82% | 0.01% |
| Oct. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 7366 | $41.90 | 120,257.0000 | 49,835,637 | 5.77% | 0.01% |
| July 30, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 8425 | $15.10 | 132,934.0000 | 49,835,637 | 5.96% | 0.02% |
| July 28, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 12946 | $14.04 | 193,666.0000 | 49,835,637 | 6.27% | 0.03% |
| July 29, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 807 | $14.00 | 192,859.0000 | 49,835,637 | 0.42% | 0.00% |
| July 30, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 51500 | $14.70 | 141,359.0000 | 49,835,637 | 26.70% | 0.10% |
| July 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 10758 | $14.45 | 206,612.0000 | 49,835,637 | 4.95% | 0.02% |
| April 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 10757 | $12.06 | 215,340.0000 | 49,835,637 | 4.76% | 0.02% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | A | Stock Option | 170000 | $0.00 | 170,000.0000 | 49,835,637 | 9999.99% | 0.34% |
| Jan. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 100 | $9.63 | 226,097.0000 | 0 | 0.04% | 0.00% |
| Jan. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 10657 | $9.09 | 226,197.0000 | 0 | 4.50% | 0.00% |
| Oct. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 10757 | $13.57 | 236,854.0000 | 0 | 4.34% | 0.00% |
| July 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 10757 | $13.14 | 247,611.0000 | 0 | 4.16% | 0.00% |
| June 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | S | Common Stock | 96815 | $12.94 | 255,462.0000 | 0 | 27.48% | 0.00% |
| Feb. 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | A | Stock Option | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| March 17, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO and Secretary | A | Stock Option | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | P | Common Stock | 6250 | $16.00 | 350,811.0000 | 0 | 1.81% | 0.00% |
| Feb. 9, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | A | Stock Option | 97518 | $0.00 | 97,518.0000 | 0 | 9999.99% | 0.00% |